Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY27.07 CNY
Change Today 0.00 / 0.00%
Volume 0.0
002099 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 07/24/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisoar pharm -a (002099) Snapshot

Open
CNY27.22
Previous Close
CNY27.07
Day High
CNY28.71
Day Low
CNY26.51
52 Week High
06/18/15 - CNY37.20
52 Week Low
12/22/14 - CNY7.95
Market Cap
20.5B
Average Volume 10 Days
27.2M
EPS TTM
CNY0.34
Shares Outstanding
757.8M
EX-Date
05/20/15
P/E TM
80.6x
Dividend
CNY0.20
Dividend Yield
0.74%
Current Stock Chart for ZHEJIANG HISOAR PHARM -A (002099)

Related News

No related news articles were found.

zhejiang hisoar pharm -a (002099) Related Businessweek News

No Related Businessweek News Found

zhejiang hisoar pharm -a (002099) Details

Zhejiang Hisoar Pharmaceutical Co., Ltd. produces and sells raw drugs and fine chemicals in China. The company offers raw drugs, such as antibody, anti-virus, cardiovascular, sugar-reducing, and worm-driven drugs for human and animal use; and fine chemicals, including medicine intermediates, and other customized and processed products. Its products primarily include clindamycin series, carbapenem series, thiamphenicol, florfenicol, voglibose, etc. The company also exports its products internationally. Zhejiang Hisoar Pharmaceutical Co., Ltd. is based in Taizhou, China.

zhejiang hisoar pharm -a (002099) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisoar pharm -a (002099) Key Developments

Zhejiang Hisoar Pharmaceutical Co., Ltd. Amends its Articles of Association

Zhejiang Hisoar Pharmaceutical Co., Ltd. amended its articles of association at the AGM held on 06 May 2015.

Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces 2014 Final Distribution Plan, Payable on May 20, 2015; Announces Board Appointments

Zhejiang Hisoar Pharmaceutical Co., Ltd. announced 2014 final distribution plan to be implemented (A shares) of cash dividend (tax included) of CNY 2.00000000 per 10 shares. The dividend is payable on May 20, 2015 to shareholders on record of May 19, 2015 with ex-date as May 20, 2015. Tax on cash dividend per 10 shares of CNY 0.20000000 (10% x CNY 2.00000000). Net cash dividend per 10 shares after tax of CNY 1.80000000 (CNY 2.00000000 - CNY 0.20000000). The company also approved the election of Guo Xiaolong and Tian Liming as directors of the company.

Zhejiang Hisoar Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 28, 2015

Zhejiang Hisoar Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002099:CH CNY27.07 CNY 0.00

002099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002099.
View Industry Companies
 

Industry Analysis

002099

Industry Average

Valuation 002099 Industry Range
Price/Earnings 61.6x
Price/Sales 11.8x
Price/Book 5.6x
Price/Cash Flow 97.1x
TEV/Sales 11.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISOAR PHARM -A, please visit www.hisoar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.